{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:06:28Z","timestamp":1781201188722,"version":"3.54.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM19\/00116"],"award-info":[{"award-number":["CM19\/00116"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM19\/00116"],"award-info":[{"award-number":["CM19\/00116"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM19\/00116"],"award-info":[{"award-number":["CM19\/00116"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto de Salud Carlos III,Spain","award":["PI 20\/00846"],"award-info":[{"award-number":["PI 20\/00846"]}]},{"name":"Instituto de Salud Carlos III,Spain","award":["PI 20\/00846"],"award-info":[{"award-number":["PI 20\/00846"]}]},{"name":"Instituto de Salud Carlos III,Spain","award":["PI 20\/00846"],"award-info":[{"award-number":["PI 20\/00846"]}]},{"DOI":"10.13039\/501100023554","name":"Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias","doi-asserted-by":"publisher","award":["PIFIISC 20\/16"],"award-info":[{"award-number":["PIFIISC 20\/16"]}],"id":[{"id":"10.13039\/501100023554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023554","name":"Fundaci\u00f3n Canaria Instituto de Investigaci\u00f3n Sanitaria de Canarias","doi-asserted-by":"publisher","award":["PIFIISC 20\/16"],"award-info":[{"award-number":["PIFIISC 20\/16"]}],"id":[{"id":"10.13039\/501100023554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02857-8","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:13:38Z","timestamp":1754482418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Glucose metabolism in heterozygous familial hypercholesterolemia\u00a0with\u00a0a founder effect and\u00a0a high diabetes prevalence: a cross-sectional study"],"prefix":"10.1186","volume":"24","author":[{"given":"Ana Mar\u00eda","family":"Gonz\u00e1lez-Lle\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeray","family":"Brito-Casillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Mart\u00edn-Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaiza","family":"Gil-Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Tugores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Scicali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ria\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Hern\u00e1ndez-Baraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Jim\u00e9nez-Monz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefa","family":"Girona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Giacomo Barbagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Masana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Boronat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"W\u00e4gner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"S\u00e1nchez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"2857_CR1","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","volume":"75","author":"SO Beheshti","year":"2020","unstructured":"Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG. Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects. J Am Coll Cardiol. 2020;75:2553\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"2857_CR2","doi-asserted-by":"crossref","unstructured":"Bouhairie VE, Goldberg AC. Familial hypercholesterolemia. In: Cardiol Clin. Philadelphia: W.B. Saunders; 2015. p. 169\u201379.","DOI":"10.1016\/j.ccl.2015.01.001"},{"key":"2857_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jacl.2018.10.012","volume":"13","author":"LE Akioyamen","year":"2019","unstructured":"Akioyamen LE, Genest J, Chu A, Inibhunu H, Ko DT, Tu JV. Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: a systematic review and meta-analysis. J Clin Lipidol. 2019;13:15\u201330.","journal-title":"J Clin Lipidol"},{"key":"2857_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","volume":"380","author":"PM Ridker","year":"2012","unstructured":"Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet. 2012;380:565\u201371.","journal-title":"Lancet"},{"issue":"3","key":"2857_CR5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3390\/nu14030600","volume":"14","author":"AM Gonz\u00e1lez-Lle\u00f3","year":"2022","unstructured":"Gonz\u00e1lez-Lle\u00f3 AM, S\u00e1nchez-Hern\u00e1ndez RM, Boronat M, W\u00e4gner AM. Diabetes and familial hypercholesterolemia: interplay between lipid and glucose metabolism. Nutrients. 2022;14(3):600.","journal-title":"Nutrients"},{"key":"2857_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183: 109119.","journal-title":"Diabetes Res Clin Pract"},{"key":"2857_CR7","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1177\/2047487319896138","volume":"27","author":"S Perez-Calahorra","year":"2020","unstructured":"Perez-Calahorra S, Civeira F, Guallar-Castill\u00f3n P, Pinto X, Banegas JR, Pedro-Botet J, et al. Behavioural cardiovascular risk factors and prevalence of diabetes in subjects with familial hypercholesterolemia. Eur J Prev Cardiol. 2020;27:1649\u201360.","journal-title":"Eur J Prev Cardiol"},{"key":"2857_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s12192-011-0265-7","volume":"16","author":"X Lu","year":"2011","unstructured":"Lu X, Liu J, Hou F, Liu Z, Cao X, Seo H, et al. Cholesterol induces pancreatic \u03b2 cell apoptosis through oxidative stress pathway. Cell Stress Chaperones. 2011;16:539\u201348.","journal-title":"Cell Stress Chaperones"},{"key":"2857_CR9","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jama.2016.14568","volume":"316","author":"LA Lotta","year":"2016","unstructured":"Lotta LA, Sharp SJ, Burgess S, Perry JRB, Stewart ID, Willems SM, et al. Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis. JAMA. 2016;316:1383\u201391.","journal-title":"JAMA"},{"key":"2857_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.artere.2021.08.003","volume":"33","author":"RM S\u00e1nchez-Hern\u00e1ndez","year":"2021","unstructured":"S\u00e1nchez-Hern\u00e1ndez RM, Gonz\u00e1lez-Lle\u00f3 AM, Tugores A, Brito-Casillas Y, Civeira F, Boronat M, et al. Familial hypercholesterolemia in Gran Canaria: founder mutation effect and high frequency of diabetes. Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis (English Edition). 2021;33:247\u201353.","journal-title":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis (English Edition)"},{"key":"2857_CR11","unstructured":"Atlas for monitoring diabetes care in the Canary Islands, 2022 [Internet]. Available from: https:\/\/cienciadedatosysalud.org\/atlas\/cuidados-diabetes-canarias."},{"key":"2857_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00125-011-2336-9","volume":"55","author":"F Soriguer","year":"2012","unstructured":"Soriguer F, Goday A, Bosch-Comas A, Bordi\u00fa E, Calle-Pascual A, Carmena R, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es study. Diabetologia. 2012;55:88\u201393.","journal-title":"Diabetologia"},{"key":"2857_CR13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jacl.2019.04.099","volume":"13","author":"RM S\u00e1nchez-Hern\u00e1ndez","year":"2019","unstructured":"S\u00e1nchez-Hern\u00e1ndez RM, Tugores A, N\u00f3voa FJ, Brito-Casillas Y, Exp\u00f3sito-Montesdeoca AB, Garay P, et al. The island of Gran Canaria: a genetic isolate for familial hypercholesterolemia. J Clin Lipidol. 2019;13:618\u201326.","journal-title":"J Clin Lipidol"},{"key":"2857_CR14","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1053\/jhep.2000.20152","volume":"32","author":"L Garc\u00eda-Villarreal","year":"2000","unstructured":"Garc\u00eda-Villarreal L, Daniels S, Shaw SH, Cotton D, Galvin M, Geskes J, et al. High prevalence of the very rare Wilson disease gene mutation Leu708Pro in the island of Gran Canaria (Canary Islands, Spain): a genetic and clinical study. Hepatology. 2000;32:1329\u201336.","journal-title":"Hepatology"},{"issue":"21","key":"2857_CR15","doi-asserted-by":"crossref","first-page":"15605","DOI":"10.3390\/ijms242115605","volume":"24","author":"NM Su\u00e1rez","year":"2023","unstructured":"Su\u00e1rez NM, Jebari-Benslaiman S, Jim\u00e9nez-Monz\u00f3n R, Benito-Vicente A, Brito-Casillas Y, Garc\u00e9s L, et al. Age, origin and functional study of the prevalent LDLR mutation causing familial hypercholesterolemia in Gran Canaria. Int J Mol Sci. 2023;24(21):15605.","journal-title":"Int J Mol Sci"},{"key":"2857_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2337\/dc17-1464","volume":"41","author":"LSF De Carvalho","year":"2018","unstructured":"De Carvalho LSF, Campos AM, Sposito AC. Proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibitors and incident type 2 diabetes: a systematic review and meta-analysis with over 96,000 patient-years. Diabetes Care. 2018;41:364\u20137.","journal-title":"Diabetes Care"},{"issue":"1","key":"2857_CR17","volume":"1","author":"L Djouss\u00e9","year":"2019","unstructured":"Djouss\u00e9 L, Song RJ, Cho K, Gaziano JM, Gagnon DR. Association of statin therapy with incidence of type 2 diabetes among US veterans. J Clin Cardiol Cardiovasc Ther. 2019;1(1): 1001.","journal-title":"J Clin Cardiol Cardiovasc Ther"},{"issue":"8","key":"2857_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043134","volume":"7","author":"MA Mart\u00ednez-Gonz\u00e1lez","year":"2012","unstructured":"Mart\u00ednez-Gonz\u00e1lez MA, Garc\u00eda-Arellano A, Toledo E, Salas-Salvad\u00f3 J, Buil-Cosiales P, Corella D, et al. A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial. PLoS ONE. 2012;7(8): e43134.","journal-title":"PLoS ONE"},{"key":"2857_CR19","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"issue":"Suppl 1","key":"2857_CR20","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"American Diabetes Association","year":"2024","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024. Diabetes Care. 2024;47(Suppl 1):S20-42.","journal-title":"Diabetes Care"},{"key":"2857_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5507\/bp.2019.021","volume":"163","author":"S Placzkowska","year":"2019","unstructured":"Placzkowska S, Pawlik-Sobecka L, Kokot I, Piwowar A. Indirect insulin resistance detection: current clinical trends and laboratory limitations. Biomed Pap. 2019;163:187\u201399.","journal-title":"Biomed Pap"},{"key":"2857_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109042","volume":"180","author":"HM Park","year":"2021","unstructured":"Park HM, Lee HS, Lee YJ, Lee JH. The triglyceride\u2013glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance. Diabetes Res Clin Pract. 2021;180: 109042.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2857_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2337\/diacare.24.3.539","volume":"24","author":"A Mari","year":"2001","unstructured":"Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 2001;24(3):539\u201348.","journal-title":"Diabetes Care"},{"key":"2857_CR24","unstructured":"Longmire J, Albright K, Lewis A, Meincke L, Hildebrand C, Leadon S, et al. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. C I R L Press Limited; 1987)."},{"issue":"11","key":"2857_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S2213-8587(24)00221-3","volume":"12","author":"A Elshorbagy","year":"2024","unstructured":"Elshorbagy A, Lyons ARM, Vallejo-Vaz AJ, Stevens CAT, Dharmayat KI, Brandts J, et al. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolemia: a worldwide cross-sectional study. Lancet Diabetes Endocrinol. 2024;12(11):811\u201323.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2857_CR26","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/dom.12703","volume":"18","author":"T Heise","year":"2016","unstructured":"Heise T, Zijlstra E, Nosek L, Heckermann S, Plum-M\u00f6rschel L, Forst T. Euglycaemic glucose clamp: what it can and cannot do, and how to do it. Diabetes Obes Metab. 2016;18:962\u201372.","journal-title":"Diabetes Obes Metab"},{"key":"2857_CR27","first-page":"e00044119","volume":"36","author":"M de F\u00e1tima Haueisen Sander Diniz","year":"2020","unstructured":"de F\u00e1tima Haueisen Sander Diniz M, Beleigoli AMR, Schmidt MI, Duncan BB, Ribeiro ALP, Vidigal PG, et al. Homeostasis model assessment of insulin resistance (HOMA-IR) and metabolic syndrome at baseline of a multicentric Brazilian cohort: ELSA-Brasil study. Cad Saude Publica. 2020;36:e00044119.","journal-title":"Cad Saude Publica"},{"key":"2857_CR28","first-page":"119","volume":"67","author":"CdC da Silva","year":"2023","unstructured":"da Silva CdC, Zambon MP, Vasques ACJ, Camilo DF, de G\u00f3es Monteiro Antonio M\u00c2R, Geloneze B. The threshold value for identifying insulin resistance (HOMA-IR) in an admixed adolescent population: a hyperglycemic clamp validated study. Arch Endocrinol Metab. 2023;67:119\u201325.","journal-title":"Arch Endocrinol Metab"},{"key":"2857_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12902-023-01291-9","volume":"23","author":"D Khalili","year":"2023","unstructured":"Khalili D, Khayamzadeh M, Kohansal K, Ahanchi NS, Hasheminia M, Hadaegh F, et al. Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes? BMC Endocr Disord. 2023;23:4.","journal-title":"BMC Endocr Disord"},{"key":"2857_CR30","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1007\/s00125-009-1443-3","volume":"52","author":"K F\u00e6rch","year":"2009","unstructured":"F\u00e6rch K, Borch-Johnsen K, Holst JJ, Vaag A. Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Diabetologia. 2009;52:1714\u201323.","journal-title":"Diabetologia"},{"key":"2857_CR31","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","volume":"373","author":"AG Tab\u00e1k","year":"2009","unstructured":"Tab\u00e1k AG, Jokela M, Akbaraly TN, Brunner EJ, Kivim\u00e4ki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373:2215\u201321.","journal-title":"Lancet"},{"issue":"1","key":"2857_CR32","first-page":"26","volume":"70","author":"A Chait","year":"1982","unstructured":"Chait A, Bierman EL, Albers JJ. Low-density lipoprotein receptor activity in cultured human skin fibroblasts: mechanism of insulin-induced stimulation. J Clin Invest. 1982;70(1):26\u201334.","journal-title":"J Clin Invest"},{"issue":"8","key":"2857_CR33","volume":"35","author":"NC Chandra","year":"2021","unstructured":"Chandra NC. A comprehensive account of insulin and LDL receptor activity over the years: a highlight on their signaling and functional role. J Biochem Mol Toxicol. 2021;35(8): e22830.","journal-title":"J Biochem Mol Toxicol"},{"issue":"5","key":"2857_CR34","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1161\/01.ATV.0000160612.18065.29","volume":"25","author":"MJ Veerkamp","year":"2005","unstructured":"Veerkamp MJ, de Graaf J, Stalenhoef AFH. Role of insulin resistance in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 2005;25(5):1026\u201331.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2857_CR35","first-page":"141","volume":"74","author":"G Paolisso","year":"1992","unstructured":"Paolisso G, Ferrannini E, Sgambato S, Varricchio M, D\u2019Onofrio F. Hyperinsulinemia in patients with hypercholesterolemia. J Clin Endocrinol Metab. 1992;74(1):141\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2857_CR36","first-page":"367","volume":"18","author":"WH Sheu","year":"1995","unstructured":"Sheu WH, Shieh S, Fuh MM, Shen DD, Jeng C, Chen YI, et al. Insulin resistance, glucose intolerance, and hyperinsulinemia. Diabetes Care. 1995;18(3):367\u201371.","journal-title":"Diabetes Care"},{"issue":"4","key":"2857_CR37","first-page":"497","volume":"13","author":"P Karhap\u00e4\u00e4","year":"1993","unstructured":"Karhap\u00e4\u00e4 P, Voutilainen E, Kovanen PT, Laakso M. Insulin resistance in familial and nonfamilial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1993;13(4):497\u2013504.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"2857_CR38","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/0026-0495(93)90154-G","volume":"42","author":"AQ Galvan","year":"1993","unstructured":"Galvan AQ, Santoro D, Natali A, Sampietro T, Boni C, Masoni A, et al. Insulin sensitivity in familial hypercholesterolemia. Metabolism. 1993;42(12):1583\u20137.","journal-title":"Metabolism"},{"issue":"1","key":"2857_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0021-9150(93)90106-5","volume":"101","author":"G Paolisso","year":"1993","unstructured":"Paolisso G, Ferrannini E, D\u2019Amore A, Volpe C, Varricchio M, D\u2019Onofrio F. Effects of physiological plasma insulin levels on glucose turnover parameters in familial hypercholesterolemia. Atherosclerosis. 1993;101(1):111\u20135.","journal-title":"Atherosclerosis"},{"issue":"4","key":"2857_CR40","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/00005344-199610000-00019","volume":"28","author":"AQ Galvan","year":"1996","unstructured":"Galvan AQ, Natali A, Baldi S, Frascerra S, Sampietro T, Galetta F, et al. Effect of reduced-fat diet with or without pravastatin on glucose tolerance and insulin sensitivity in patients with primary hypercholesterolemia. J Cardiovasc Pharmacol. 1996;28(4):595\u2013602.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"8","key":"2857_CR41","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.2337\/db17-0173","volume":"66","author":"H Xu","year":"2017","unstructured":"Xu H, Ryan KA, Jaworek TJ, Southam L, Reid JG, Overton JD, et al. Familial hypercholesterolemia and type 2 diabetes in the Old Order Amish. Diabetes. 2017;66(8):2054\u20138.","journal-title":"Diabetes"},{"issue":"10","key":"2857_CR42","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/eci.12818","volume":"47","author":"N Koks","year":"2017","unstructured":"Koks N, de Vries MA, Birnie E, Alipour A, Castro CM. Glucose-dependent leucocyte activation in familial hypercholesterolemia. Eur J Clin Invest. 2017;47(10):839\u201346.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"2857_CR43","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jacl.2023.03.008","volume":"17","author":"M Paquette","year":"2023","unstructured":"Paquette M, Bernard S, Cariou B, Hegele RA, Genest J, Trinder M, et al. Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia. J Clin Lipidol. 2023;17(3):376\u201383.","journal-title":"J Clin Lipidol"},{"issue":"6","key":"2857_CR44","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","volume":"256","author":"ACM Jansen","year":"2004","unstructured":"Jansen ACM, van Aalst-Cohen ES, Tanck MW, Trip MD, Lansberg PJ, Liem AH, et al. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J Intern Med. 2004;256(6):482\u201390.","journal-title":"J Intern Med"},{"issue":"2","key":"2857_CR45","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1161\/ATVBAHA.123.319957","volume":"44","author":"M Paquette","year":"2024","unstructured":"Paquette M, Cariou B, Bernard S, Hegele RA, Gallo A, Genest J, et al. Increased FH-risk-score and diabetes are cardiovascular risk equivalents in heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2024;44(2):505\u201312.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2857_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-0495(98)90183-4","volume":"47","author":"BV Howard","year":"1998","unstructured":"Howard BV, Mayer-Davis EJ, Goff D, Zaccaro DJ, Laws A, Robbins DC, et al. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Metabolism. 1998;47(1):1\u201310.","journal-title":"Metabolism"},{"key":"2857_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175672","volume":"947","author":"L Alvarez- Jimenez","year":"2023","unstructured":"Alvarez-Jimenez L, Morales-Palomo F, Moreno-Caba\u00f1as A, Ortega JF, Mora-Rodr\u00edguez R. Effects of statin therapy on glycemic control and insulin resistance: a systematic review and meta-analysis. Eur J Pharmacol. 2023;947: 175672.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2857_CR48","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2337\/dc21-1284","volume":"45","author":"P Wu","year":"2022","unstructured":"Wu P, Moon JY, Daghlas I, Franco G, Porneala BC, Ahmadizar F, et al. Obesity partially mediates the diabetogenic effect of lowering LDL cholesterol. Diabetes Care. 2022;45(1):232\u201340.","journal-title":"Diabetes Care"},{"issue":"5","key":"2857_CR49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/met.2012.0063","volume":"10","author":"V Panz","year":"2012","unstructured":"Panz V, Immelman A, Paiker J, Pilcher G, Raal F. High-dose statin therapy does not induce insulin resistance in patients with familial hypercholesterolemia. Metab Syndr Relat Disord. 2012;10(5):351\u20137.","journal-title":"Metab Syndr Relat Disord"},{"issue":"2","key":"2857_CR50","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1464-5491.2005.01739.x","volume":"23","author":"M Boronat","year":"2006","unstructured":"Boronat M, Varillas VF, Saavedra P, Su\u00e1rez V, Bosch E, Carrillo A, et al. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria. Diabet Med. 2006;23(2):148\u201355.","journal-title":"Diabet Med"},{"issue":"6","key":"2857_CR51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/sj.ejcn.1601401","volume":"56","author":"P de Pablos-Velasco","year":"2002","unstructured":"de Pablos-Velasco P, Mart\u00ednez-Mart\u00edn F, Rodr\u00edguez-P\u00e9rez F. Prevalence of obesity in a Canarian community. Association with type 2 diabetes mellitus: the Gu\u00eda Study. Eur J Clin Nutr. 2002;56(6):557\u201360.","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"2857_CR52","volume":"57","author":"AM Cebri\u00e1n Cuenca","year":"2025","unstructured":"Cebri\u00e1n Cuenca AM, Escalada J. Prevalence of obesity and diabetes in Spain. Evolution in the last 10 years. Aten Primaria. 2025;57(1): 101502.","journal-title":"Aten Primaria"},{"key":"2857_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.diabres.2015.10.024","volume":"111","author":"I Marcelino-Rodr\u00edguez","year":"2016","unstructured":"Marcelino-Rodr\u00edguez I, Elosua R, P\u00e9rez MdelCR, Fern\u00e1ndez-Berg\u00e9s D, Guembe MJ, Alonso TV, et al. On the problem of type 2 diabetes-related mortality in the Canary Islands, Spain: the DARIOS study. Diabetes Res Clin Pract. 2016;111:74\u201382.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2857_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12889-019-8137-7","volume":"20","author":"MC Rodr\u00edguez P\u00e9rez","year":"2020","unstructured":"Rodr\u00edguez P\u00e9rez MC, Chines C, Pedrero Garc\u00eda AJ, Sousa D, Cuevas Fern\u00e1ndez FJ, Marcelino-Rodr\u00edguez I, et al. Major amputations in type 2 diabetes between 2001 and 2015 in Spain: regional differences. BMC Public Health. 2020;20(1):54.","journal-title":"BMC Public Health"},{"issue":"7","key":"2857_CR55","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/ndt\/gfp761","volume":"25","author":"V Lorenzo","year":"2010","unstructured":"Lorenzo V, Boronat M, Saavedra P, Rufino M, Maceira B, Novoa FJ, et al. Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands: an analysis based on estimated population at risk. Nephrol Dial Transplant. 2010;25(7):2283\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"2857_CR56","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1111\/j.1464-5491.2005.01745.x","volume":"22","author":"M Boronat","year":"2005","unstructured":"Boronat M, Chirino R, Varillas VF, Saavedra P, Marrero D, Fabregas M, et al. Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals. Diabet Med. 2005;22(12):1751\u20136.","journal-title":"Diabet Med"},{"issue":"10","key":"2857_CR57","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1039\/c1fo10082c","volume":"2","author":"E N\u00fa\u00f1ez-Gonz\u00e1lez","year":"2011","unstructured":"N\u00fa\u00f1ez-Gonz\u00e1lez E, Serra-Majem L, Fika-Hern\u00e1ndo M, Fern\u00e1ndez-Vallhonrat B, Bravo-Mart\u00ednez J, Mart\u00edn-Ferrer JM, et al. Determinants of specific food consumption in the Canary Islands (Spain). Food Funct. 2011;2(10):627\u201332.","journal-title":"Food Funct"},{"key":"2857_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-12805-w","volume":"22","author":"D Godenau","year":"2022","unstructured":"Godenau D, Martin-Rodriguez G, Gonzalez-Gomez JI, Caceres-Hernandez JJ. Food consumption in the Canary Islands: nutritional implications of food imports and local production. BMC Public Health. 2022;22: 1187.","journal-title":"BMC Public Health"},{"issue":"4","key":"2857_CR59","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1590\/S1135-57272009000400008","volume":"83","author":"A Cabrera de Le\u00f3n","year":"2009","unstructured":"Cabrera de Le\u00f3n A, Castillo Rodr\u00edguez JC, Dom\u00ednguez Coello S, Rodr\u00edguez P\u00e9rez MC, Brito D\u00edaz B, Borges \u00c1lamo C, et al. Estilo de vida y adherencia al tratamiento de la poblaci\u00f3n canaria con diabetes mellitus tipo 2. Rev Esp Salud Publica. 2009;83(4):567\u201375.","journal-title":"Rev Esp Salud Publica"},{"issue":"1","key":"2857_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40198-w","volume":"14","author":"JG Serrano","year":"2023","unstructured":"Serrano JG, Ord\u00f3\u00f1ez AC, Santana J, S\u00e1nchez-Ca\u00f1adillas E, Arnay M, Rodr\u00edguez-Rodr\u00edguez A, et al. The genomic history of the indigenous people of the Canary Islands. Nat Commun. 2023;14(1): 7610.","journal-title":"Nat Commun"},{"key":"2857_CR61","unstructured":"World Health Organization. Classification of Diabetes Mellitus [Internet]. Geneva: WHO; 2019. Available from: http:\/\/apps.who.int\/bookorders"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02857-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02857-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02857-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:29:17Z","timestamp":1757345357000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02857-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2857"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02857-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was\u00a0approved by the Gran Canaria ethics committee\u00a0(Committee on Ethics and Research with Drugs of the Province of Las Palmas,\u00a0Las Palmas de Gran Canaria, Spain; approval code:\u00a0CEIm H.U.G.C. Dr. Negr\u00edn: 2020\u2013164-1) and by the local Italian Ethics Committee, in accordance with the ethical standards of the institutional and national research committees. This study was conducted following the ethical principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"322"}}